Search results for "Sclerosis"

showing 10 items of 1583 documents

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis

2019

\(\bf Objective:\) The autoimmune disease Multiple Sclerosis (MS) represents a heterogeneous disease pattern with an individual course that may lead to permanent disability. In addition to immuno-modulating therapies patients benefit from symptomatic approaches like intrathecal corticosteroid therapy (ICT), which is frequently applied in a growing number of centers in Germany. ICT reduces spasticity, which elongates patient's walking distance and speed, thus improves quality of life. \(\bf Methods:\) In our study we set out to investigate cerebrospinal fluid (CSF) parameters and clinical predictors for response to ICT. Therefore, we analyzed 811 CSF samples collected from 354 patients over …

disease progressionNeurologyclinical predictorparasitic diseasesintrathecal corticosteroid therapyddc:610multiple sclerosiscerebrospinal fluidlcsh:Neurology. Diseases of the nervous systemlcsh:RC346-429Original ResearchFrontiers in Neurology
researchProduct

Chronic cerebrospinal venous insufficiency: state of the art and research challenges

2012

This review discusses a potential vascular basis for multiple sclerosis (MS). The idea that MS could be related to vascular disease is not new, with the first reports describing connections between veins and MS plaques dating from the 19th century. The venous abnormalities found in MS patients, the socalled chronic cerebrospinal venous insufficiency, are currently interpreted as congenital venous malformations. Catheter venography is regarded as the gold standard to assess these lesions, while other tests, such as Doppler sonography and magnetic resonance venography, are much less accurate. Importantly, a relationship between venous pathologies and MS has not yet been proven, especially reg…

doppler ultrasonographyultrasound applicationsmultiple sclerosisvascular malformationsjugular veinsphlebographyPhlebolymphology
researchProduct

Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies.

2022

IntroductionCardiovascular disease (CVD) is a major cause of morbidity and mortality throughout the world. The LIPIDOGRAM2015 study was performed to estimate the prevalence of risk factors for atherosclerotic diseases as well as cardiovascular and related disorders in the primary care setting in Poland. The LIPIDOGEN2015 sub-study was designed to include a random cohort of patients in order to analyse parameters related to lipid metabolism, oxidative stress, inflammatory responses, autoimmune disorders, and gene variants that confer susceptibility to cardiometabolic and atherosclerotic diseases.Material and methodsThe recruitment was carried out by 438 primary care physicians in Poland. The…

dyslipidaemiabusiness.industryGeneral Medicinemedicine.diseaseBioinformaticsmedicine.disease_causeScreening analysiscardiovascular diseasesinflammationmedicineoxidative stressatherosclerosisbusinesscardiometabolic diseasesgenesDyslipidemiaOxidative stressArchives of medical science : AMS
researchProduct

Cardiovascular diseases and HCV infection: a simple association or more?

2013

HCV infection, metabolic disorders and cardiovascular alterations, considered alone or in combination, are common conditions in a large proportion of the general population. Consequently, determining whether the association of HCV infection with cardiometabolic disorders is simply coincidental or, conversely, caused by pathogenetic mechanisms (in)directly linking chronic HCV infection to these disorders, would be of extreme relevance. Several clinical studies have shown that metabolic disorders—namely, type 2 diabetes,1 insulin resistance (IR)2 and hepatic steatosis3—are highly prevalent in patients with chronic hepatitis C (CHC) compared with non-infected patients. Experimental and clinica…

education.field_of_studyVery low-density lipoproteinCholesterolPopulationGastroenterologyHeartHepatitis C ChronicBiologyAtherosclerosismedicine.diseasechemistry.chemical_compoundHigh-density lipoproteinInsulin resistancechemistryCardiovascular DiseasesDiabetes mellitusLow-density lipoproteinImmunologymedicineHumansMetabolic syndromehcv cardiovasculareducationGut
researchProduct

SAT0390 Microrna Expression Profile in Fibromyalgia Patients: A Pilot Matched Case Control Study

2013

Background Fibromyalgia (FM) is a clinical syndrome characterized by musculoskeletal pain and tenderness. Diagnosis is mainly based on exclusion of other resembling diseases since validated biological tests are still lacking. Identification of disease-related markers will enable clinicians to effectively diagnose FM, follow the progress of the disease, monitor the effects of therapeutic approaches and probably develop preventive programs. MicroRNAs (miRNAs) are pieces of 18-25 nucleotides capable of regulating gene expression. Changes in their expression levels have been linked to environmental responses as well as to pathological processes. Their recent association to some other chronic di…

education.field_of_studybusiness.industryMultiple sclerosisImmunologyPopulationArthritisMicroRNA Expression Profilemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyReal-time polymerase chain reactionRheumatologyRheumatoid arthritisFibromyalgiaImmunologymedicineChronic fatigue syndromeImmunology and AllergyeducationbusinessAnnals of the Rheumatic Diseases
researchProduct

Is season of birth associated with multiple sclerosis?

2000

Objective - To compare the monthly distribution of multiple sclerosis (MS) patients' births with that of the Sicilian population. Background -Studies on the association between season of birth and risk of MS are scanty and controversial. Design and methods - Archives of the Institute of Neuropsychiatry of the Universities of Palermo and Catania were searched up to 1995 for definite MS patients (McDonald & Halliday criteria). The monthly distribution of MS patients' births (N=965) was compared with that of the Sicilian population (N = 5,608,307). Results -The distribution of births among MS patients compared with the general population was not different when tested by the X 2 statistic (P > …

education.field_of_studymedicine.medical_specialtyMonth of birthSeason of birthbusiness.industryMultiple sclerosisPopulationGeneral Medicinemedicine.diseaseSurgeryNeurologyEpidemiologyMedicineNeurology (clinical)Risk factorbusinesseducationDemographyActa Neurologica Scandinavica
researchProduct

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors

2009

Type 2 diabetes is a chronic, progressive disease with a multi-faceted pathophysiology. Beyond the known defects of insulin resistance and beta-cell insufficiency, derangement of incretin hormones normally produced from the gut wall in response to food intake play an important role. In recent years, the 'incretin-based' therapies (IBTs) have been developed to address hyperglycemia through either mimicking the action of the endogenous incretin glucagon-like polypeptide (GLP-1) (GLP-1 receptor agonists) or by inhibiting the activity of the enzyme that degrades GLP-1 (the dipeptyl peptidase-4 inhibitors).We reviewed available evidence on the glucose lowering and anti-atherogenic effects of IBT…

endocrine systemmedicine.medical_specialtyDipeptidyl Peptidase 410265 Clinic for Endocrinology and DiabetologyIncretin610 Medicine & healthType 2 diabetesCarbohydrate metabolismIncretinsInsulin resistancecardiovascular risk diabetes DPP-4 inhibitors GLP-1 analoguesGlucagon-Like Peptide 1Risk FactorsInternal medicineDiabetes mellitusmedicineAnimalsHumans2736 Pharmacology (medical)Pharmacology (medical)Dipeptidyl peptidase-4PharmacologyClinical Trials as TopicDipeptidyl-Peptidase IV Inhibitorsbusiness.industrydigestive oral and skin physiologyGeneral MedicineAtherosclerosismedicine.diseaseGlucose3004 PharmacologyEndocrinologyPostprandialDiabetes Mellitus Type 2aterosclerosibusinesshormones hormone substitutes and hormone antagonistsHormoneExpert Opinion on Investigational Drugs
researchProduct

Sildenafil inhibits the proliferation of cultured human endothelial cells.

2013

The proliferation of endothelial cells plays a crucial role in the development of intraplaque angiogenesis (IPA). IPA is a major source of intraplaque hemorrhage and therefore contributes to the destabilization of atherosclerotic plaques. Therefore, the aim of the present study was to examine, whether sildenafil inhibits endothelial cell growth. The proliferation of human endothelial cells derived from umbilical cord veins (HUVEC) was examined on DNA level by measurements of (3H)-thymidine incorporation. Cell viability was analyzed using trypan blue staining. The proliferation of cultured human endothelial cells was significantly decreased by 1 μmol/l (-48.4%) and 10 μmol/l (-89.6%) sildena…

endothelial proliferationsildenafilcardiovascular systematherosclerosisbasic fibroblast growth factorArticleplaque angiogenesisrespiratory tract diseasesInternational journal of biomedical science : IJBS
researchProduct

Estrogen Receptor and Vascular Aging.

2021

Cardiovascular diseases remain an age-related pathology in both men and women. These pathologies are 3-fold more frequent in men than in women before menopause, although this difference progressively decreases after menopause. The vasculoprotective role of estrogens are well established before menopause, but the consequences of their abrupt decline on the cardiovascular risk at menopause remain debated. In this review, we will attempt to summarize the main clinical and experimental studies reporting the protective effects of estrogens against cardiovascular diseases, with a particular focus on atherosclerosis, and the impact of aging and estrogen deprivation on their endothelial actions. Th…

endotheliumvascular agingGeriatricsestradiolRC952-954.6menopauseGeneral Medicineatherosclerosisestrogen receptorFrontiers in aging
researchProduct

Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?

2010

Objectives The aim of this report is to assess the safety of endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI). Although balloon angioplasty and stenting seem to be safe procedures, there are currently no data on the treatment of a large group of patients with this vascular pathology. Methods A total of 564 endovascular procedures (balloon angioplasty or, if this procedure failed, stenting) were performed during 344 interventions in 331 CCSVI patients with associated multiple sclerosis. Results Balloon angioplasty alone was performed in 192 cases (55.8%), whereas the stenting of at least one vein was required in the remaining 152 cases (44.2%). There were no majo…

endovascular treatmentAdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentmedicine.medical_treatmentFemoral veinBalloonYoung AdultPostoperative ComplicationsCentral Nervous System DiseasesAngioplastymedicineHumansVeinAgedbusiness.industryEndovascular ProceduresStentPhlebographyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryVenous thrombosisChronic cerebrospinal venous insufficiencymedicine.anatomical_structureVenous InsufficiencyChronic DiseaseFemaleStentsRadiologyCardiology and Cardiovascular MedicineVenous malformationbusinessvenous malformationAngioplasty BalloonMagnetic Resonance AngiographyPhlebology: The Journal of Venous Disease
researchProduct